A shift in how NICE measures treatment benefits could restrict access to some medicines, particularly those improving quality of life without extending survival. Alan Lamb explains the change from EQ-...

The UK holds one of the world's most valuable health data assets, with GP records capturing around 90% of a patient's NHS interactions over their lifetime. ABPI Director Janet Messer explains why the ...

The NHS Federated Data Platform, the Single Patient Record and the Health Data Research Service have become hot topics of discussion in recent times. This article explains what each one is, and how th...

New projects to move UK science away from animal testing

11 top benefits of the largest services trade deal concluded by the UK

Dr Amit Aggarwal, ABPI Executive Director of Medical Affairs and Strategic Partnerships, and Alex Fell, PMCPA Chief Executive, discuss the latest data published on Disclosure UK, the industry database...

Proposed changes to the headline payment percentage and consultation procedure of the statutory scheme to control the cost of branded health service medicines.

YouTube video by Association of the British Pharmaceutical Industry

This plan for Wales sets out the ABPI’s vision for improving health outcomes, supporting the health system, and stimulating inward investment and economic growth.

NHS patients in England rank 7th in Europe for access to newly approved medicines, according to the latest EFPIA W.A.I.T. Indicator report — but significant gaps remain, particularly for cancer and ra...

Dr Amit Aggarwal discusses the importance of NHS-industry relationships, and the safeguards in place to ensure they always put patients and the NHS first.

By Marion Laverty, Head of Public Affairs, Northern Ireland, Association of the British Pharmaceutical Industry (ABPI)

YouTube video by Association of the British Pharmaceutical Industry

Dr Amit Aggarwal discusses the importance of NHS-industry relationships, and the safeguards in place to ensure they always put patients and the NHS first.

Dr Amit Aggarwal discusses the importance of NHS-industry relationships, and the safeguards in place to ensure they always put patients and the NHS first.

YouTube video by Association of the British Pharmaceutical Industry

Alan Thomas from Wales is a patient advocate for rare diseases and Ataxia in particular. Known as ‘the rare disease warrior’; he founded the charity Ataxia and Me, which now has a global following. He...

Dan O’Connor reflects on the need for greater investment in prevention, as well as the need for equity, for this year’s Rare Disease Day.

In 2020, we spoke to Anna Turner and her Mum Jenna from Waringstown, Northern Ireland, to get their perspective on living with hypophosphatasia (HPP). In 2024 we caught up with Jenna again to see how ...

New report by the Association of the British Pharmaceutical Industry (ABPI) and the NC3Rs examines the UK's capabilities in developing human relevant pre-clinical models for medicine development.